| Company Name | GeneReach Biotechnology Corp. |
| Stock Name | GeneReach |
| Stock Code | 4171 |
| Market Type | OTC-Listed |
| Industry Type | Agricultural Biotechnology |
| Principal Activities | Animal Use Medicine Manufacturing / Biotechnology Services / Medical Materials and Equipment Manufacturing / Precision Instruments Manufacturing |
| Date of Establishment | 2004-11-12 |
| Date of OTC | 2014-08-14 |
| Capital | NT$ 343,400,000 |
| Chairman | Leo Liu |
| Stock Transfer Agent | Fubon Financial Holding Co., Ltd. |
| Auditors | KPMG Taiwan |
| Principal Office | No.19, Keyuan 2nd Road, Central Taiwan Science Park, Taichung City 407, Taiwan |
| Tel | 04-24639869 |
| Fax | 04-24638255 |
| genereach@gmail.com |
| Executives | |
|---|---|
| Chairman of the Board | Leo Liu MSc, Animal Science, Oregon State University |
| Chief Executive Officer (CEO) | Grace Chang Ph.D. Ph.D., Nutritional Sciences and Toxicology, University of Califonia, Berkeley |
| Executive Director | Su Chen MSc, Biochemistry and Molecular Biology, National Yang-Ming University |
| General Manager | Teng, Ping-Hua Ph.D. Ph.D., Animal Science and Biotechnology, Tunghai University |
| Vice President of Research & Development | Alison Lee Ph.D. Ph.D., Microbiology, Oregon State University |
| Vice President of Global Sales | Simon Chung MSc, Animal Science and Biotechnology, Tunghai University |
| Vice President of Compliance Operation | Yu-Wen Huang BS, Plant Pathology, National Chung-Hsing University |
